Varian Medical Systems, Inc. (NYSE:VAR) Shares Sold by Blair William & Co. IL

Blair William & Co. IL reduced its position in shares of Varian Medical Systems, Inc. (NYSE:VAR) by 7.6% during the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 3,499 shares of the medical equipment provider’s stock after selling 289 shares during the period. Blair William & Co. IL’s holdings in Varian Medical Systems were worth $602,000 at the end of the most recent quarter.

A number of other institutional investors have also modified their holdings of the business. Aigen Investment Management LP acquired a new position in Varian Medical Systems in the third quarter worth approximately $27,000. FNY Investment Advisers LLC acquired a new stake in shares of Varian Medical Systems during the 3rd quarter valued at $27,000. CWM LLC boosted its stake in shares of Varian Medical Systems by 76.1% during the 3rd quarter. CWM LLC now owns 199 shares of the medical equipment provider’s stock worth $34,000 after acquiring an additional 86 shares in the last quarter. Ovata Capital Management Ltd acquired a new position in shares of Varian Medical Systems in the 2nd quarter worth $25,000. Finally, SRS Capital Advisors Inc. acquired a new position in shares of Varian Medical Systems in the 2nd quarter worth $29,000. Hedge funds and other institutional investors own 92.32% of the company’s stock.

VAR has been the subject of a number of recent analyst reports. Jefferies Financial Group increased their price target on Varian Medical Systems from $130.00 to $178.00 and gave the company a “buy” rating in a research report on Monday, August 3rd. Robert W. Baird downgraded shares of Varian Medical Systems from an “outperform” rating to a “neutral” rating and set a $178.00 target price on the stock. in a research report on Wednesday, October 28th. UBS Group downgraded shares of Varian Medical Systems to an “in-line” rating in a research report on Tuesday, November 17th. BTIG Research lowered shares of Varian Medical Systems from a “buy” rating to a “neutral” rating in a research note on Monday, August 10th. Finally, Barrington Research downgraded shares of Varian Medical Systems from an “outperform” rating to an “underperform” rating in a research note on Wednesday, October 28th. Three analysts have rated the stock with a sell rating, seven have given a hold rating and one has issued a buy rating to the company’s stock. Varian Medical Systems has an average rating of “Hold” and a consensus price target of $145.55.

NYSE VAR opened at $173.51 on Friday. Varian Medical Systems, Inc. has a 1-year low of $89.62 and a 1-year high of $176.19. The firm’s fifty day simple moving average is $172.59 and its 200-day simple moving average is $149.79. The company has a market capitalization of $15.78 billion, a PE ratio of 56.52 and a beta of 1.16.

Varian Medical Systems (NYSE:VAR) last issued its earnings results on Tuesday, October 27th. The medical equipment provider reported $1.12 earnings per share for the quarter, topping the consensus estimate of $0.98 by $0.14. Varian Medical Systems had a return on equity of 19.68% and a net margin of 8.82%. During the same period last year, the company posted $1.21 EPS. Analysts anticipate that Varian Medical Systems, Inc. will post 3.77 EPS for the current fiscal year.

In other Varian Medical Systems news, insider Kolleen T. Kennedy sold 543 shares of the business’s stock in a transaction dated Thursday, October 8th. The stock was sold at an average price of $171.91, for a total value of $93,347.13. Following the completion of the sale, the insider now owns 27,661 shares of the company’s stock, valued at $4,755,202.51. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. Also, insider Kolleen T. Kennedy sold 400 shares of the company’s stock in a transaction dated Monday, September 14th. The stock was sold at an average price of $173.48, for a total value of $69,392.00. Following the sale, the insider now owns 27,518 shares of the company’s stock, valued at approximately $4,773,822.64. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 2,286 shares of company stock worth $395,288. Insiders own 0.78% of the company’s stock.

Varian Medical Systems Company Profile

Varian Medical Systems, Inc designs, manufactures, sells, and services medical devices and software products for treating cancer and other medical conditions worldwide. It operates in Oncology Systems and Proton Solutions segments. The Oncology Systems segment offers hardware and software products for treating cancer with radiotherapy, fixed field intensity-modulated radiation therapy, image-guided radiation therapy, volumetric modulated arc therapy, stereotactic radiosurgery, stereotactic body radiotherapy, and brachytherapy, as well as quality assurance equipment.

Read More: Swap

Want to see what other hedge funds are holding VAR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Varian Medical Systems, Inc. (NYSE:VAR).

Institutional Ownership by Quarter for Varian Medical Systems (NYSE:VAR)